• HOME
  • ABOUT US
    • CAREERS
  • TECHNOLOGY
  • NEWS
  • SERVICES
    • RESEARCH AND DEVELOPMENT
  • PRODUCTS
  • CONTACT
Type and hit ENTER
  • HOME
  • ABOUT US
    • CAREERS
  • TECHNOLOGY
  • NEWS
  • SERVICES
    • RESEARCH AND DEVELOPMENT
  • PRODUCTS
  • CONTACT
GET CONNECTED
  • HOME
  • ABOUT US
    • CAREERS
  • TECHNOLOGY
  • NEWS
  • SERVICES
    • RESEARCH AND DEVELOPMENT
  • PRODUCTS
  • CONTACT
ProAxsis releases new NEATstik® data at the Irish Thoracic Society Conference 2021
Share
neutrophil elastase airways test
News

ProAxsis releases new NEATstik® data at the Irish Thoracic Society Conference 2021

November 15, 2021
-
Posted by Jessica Robinson

Dr Darragh McCafferty, ProAxsis’ Head of Assay Development, will be presenting new data on the company’s ongoing project to develop a quantitative version of its neutrophil elastase point-of-care test (NEATstik®) at the Irish Thoracic Society (ITS) annual conference, taking place in virtual format between the 19th-20th November. 

Dr McCafferty will be presenting a poster, entitled “The Quantitative Measurement of Active Neutrophil Elastase in Sputum using a Point of Care Test and Reader Device”, during the E-poster Review & Discussion session on the 19th of November between 8am and 9am.  This project is being conducted collaboratively with the Connected Health Innovation Centre (CHIC) team at Ulster University.

Following the conference, copies of the e-poster will be available online at www.proaxsis.com. For further information on how ProAxsis can support with the measurement of inflammatory biomarkers, including active protease biomarkers and cytokines, or for any other queries, please contact info@proaxsis.com or phone us on +44 (0) 28 9073 0444.

November 15, 2021

Related News

Other posts that you should not miss.
Announcements, News, ProteaseTag®

ProAxsis successfully licenses additional intellectual property from The Queen’s University of Belfast

May 10, 2017
-
Posted by Webmaster

ProAxsis Limited (www.proaxsis.com) is delighted to announce that it has secured a second licensing agreement with the Queen’s …

Read More
May 10, 2017
Posted by Webmaster
Neutrophil Elastase Immunoassay, News, ProteaseTag®

ProteaseTag® Active Neutrophil Elastase Immunoassay used to predict future risk of exacerbation in bronchiectasis

December 23, 2016
-
Posted by Webmaster

In a significant new study, a team at the University of Dundee has shown for the first time that sputum …

Read More
December 23, 2016
Posted by Webmaster
Announcements, News

ProAxsis Limited supported by Innovate UK to accelerate work on inflammatory biomarkers associated with COVID-19

December 10, 2020
-
Posted by David Ribeiro

ProAxsis (www.proaxsis.com), the Belfast-based respiratory diagnostics company, today announces that it has been awarded a high impact …

Read More
December 10, 2020
Posted by David Ribeiro
← PREVIOUS POST
ProAxsis establishes new internal Finance team
NEXT POST →
ProAxsis CEO attending DxPx conference
Categories
  • Announcements
  • Conferences
  • NEATstik®
  • Neutrophil Elastase Immunoassay
  • News
  • ProteaseTag®
  • Trials
  • Video
GET CONNECTED
RECENT POSTS
  • ProAxsis signs global in-licensing agreement with AstraZeneca for COVID-19 serology test
    June 7, 2021

    ProAxsis Limited (www.proaxsis.com), the Belfast-based respiratory diagnostics company, is delighted to announce it …

  • ProAxsis Ltd CEO Update Report – May 2021
    May 21, 2021

    Introduction In parallel with the release of the company’s 2020 financial statements, I …

  • ProAxsis Limited enters licensing agreement with top Swiss University as it continues to develop novel new products in the fight against fractures and other metabolic bone diseases
    February 21, 2021

    ProAxsis (www.proaxsis.com), the Belfast-based diagnostics company, and a collaboration of the University of …


ProAxsis Ltd
Unit 1B, Concourse Building 3,
Catalyst Inc,
Queen’s Road, Titanic Quarter,
Belfast,
BT3 9DT,
Northern Ireland

tel +44 (0)28 9073 0444
email info@proaxsis.com

RECENT NEWS
  • May 17, 2022
    Belfast Telegraph Awards
  • May 16, 2022
    ProAxsis announces “impressive” results in Performance Evaluation of COVID-19 antibody test
  • January 31, 2022
    ProAxsis enhances availability of product portfolio in Asia via new partnership with Kyberlife
Copyright © 2016-2021 - ProAxsis - All rights reserved. 
ProAxsis releases new NEATstik® data at the Irish Thoracic Society Conference 2021 - ProAxsis